Sorafenib is a multikinase inhibitor targeting several serine/threonine and receptor tyrosine kinases. The drug is marketed as Nexavar and is used in the treatment of renal cell carcinoma (Kidney cancer). It is also being studied as treatment in other types of cancer.
More information
More information
Related categories 1
Sites 1
Official site for obtaining this oral multiple kinase inhibitor for the treatment of patients with liver or kidney cancer. Information provided on how to obtain drug.
Official site for obtaining this oral multiple kinase inhibitor for the treatment of patients with liver or kidney cancer. Information provided on how to obtain drug.
